| Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2-Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study | |
| Zhao, Yannan; Liu, Cheng; Zhang, Yingjian; Gong, Chengcheng; Li, Yi; Xie, Yizhao; BingruiWu; ZhongyiYang; Wangl, Biyun | |
| 刊名 | SCIENTIFIC REPORTS
 |
| 2018 | |
| 卷号 | 8 |
| ISSN号 | 2045-2322 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3605254 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Zhao, Yannan,Liu, Cheng,Zhang, Yingjian,et al. Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2-Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study[J]. SCIENTIFIC REPORTS,2018,8. |
| APA | Zhao, Yannan.,Liu, Cheng.,Zhang, Yingjian.,Gong, Chengcheng.,Li, Yi.,...&Wangl, Biyun.(2018).Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2-Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study.SCIENTIFIC REPORTS,8. |
| MLA | Zhao, Yannan,et al."Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2-Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study".SCIENTIFIC REPORTS 8(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论